Replimune Group Return on Net Operating Assets Trends

Replimune Group, Inc. (REPL)

7.65 -0.04 (-0.52%) USD | NASDAQ | Feb 27, 16:00

7.80 +0.15 (+1.96%) After-Hours: 20:00

View Return on Net Operating Assets for REPL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Sarepta Therapeutics, Inc.	Upgrade
Bristol Myers Squibb Co.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade